ATE316653T1 - Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe - Google Patents

Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe

Info

Publication number
ATE316653T1
ATE316653T1 AT01976049T AT01976049T ATE316653T1 AT E316653 T1 ATE316653 T1 AT E316653T1 AT 01976049 T AT01976049 T AT 01976049T AT 01976049 T AT01976049 T AT 01976049T AT E316653 T1 ATE316653 T1 AT E316653T1
Authority
AT
Austria
Prior art keywords
body fluid
fluid sample
test
inflammatory
direct detection
Prior art date
Application number
AT01976049T
Other languages
English (en)
Inventor
Michael Rud Lassen
Morten Breindahl
Original Assignee
Besst Test Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besst Test Aps filed Critical Besst Test Aps
Application granted granted Critical
Publication of ATE316653T1 publication Critical patent/ATE316653T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01976049T 2000-10-17 2001-10-12 Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe ATE316653T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001550 2000-10-17
US24217600P 2000-10-23 2000-10-23

Publications (1)

Publication Number Publication Date
ATE316653T1 true ATE316653T1 (de) 2006-02-15

Family

ID=26068897

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01976049T ATE316653T1 (de) 2000-10-17 2001-10-12 Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe

Country Status (8)

Country Link
US (1) US20040048274A1 (de)
EP (1) EP1340077B1 (de)
JP (1) JP2004511802A (de)
AT (1) ATE316653T1 (de)
AU (1) AU2001295442A1 (de)
DE (1) DE60116889T2 (de)
ES (1) ES2257446T3 (de)
WO (1) WO2002033408A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040072237A1 (en) * 2001-12-26 2004-04-15 Barry Schweitzer Use of cytokines secreted by dendritic cells
EP1532449B1 (de) * 2002-08-27 2010-05-12 Kimberly-Clark Worldwide, Inc. Membran-basierendes verfahren unter verwendung von zeitaufgelösten fluoreszenzmessungen
US8068990B2 (en) 2003-03-25 2011-11-29 Hologic, Inc. Diagnosis of intra-uterine infection by proteomic analysis of cervical-vaginal fluids
EP1907851B1 (de) * 2005-07-28 2011-10-19 Vittorio Enrico Avvedimento Stimulatorische autoantikörper gegen den pdgf-rezeptor als pathologische marker und therapeutisches target
US8187817B2 (en) * 2005-08-02 2012-05-29 Xbiotech, Inc. Diagnosis, treatment, and prevention of vascular disorders using IL-1 autoantibodies
GB0616238D0 (en) 2006-08-15 2006-09-27 Inst Animal Health Ltd Diagnostic Test
US20100135908A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Delivery devices for modulating inflammation
US20100136097A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100137246A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
US20100136094A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136095A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100136096A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems for modulating inflammation
US20100135983A1 (en) * 2008-12-02 2010-06-03 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Anti-inflammatory compositions and methods
EP2745114B1 (de) * 2011-09-16 2018-10-17 Credo Biomedical Pte Ltd. Molekulare diagnostische testvorrichtung und verwendungsverfahren
US8852873B2 (en) 2012-04-13 2014-10-07 Diabetomics, Llc Maternal biomarkers for gestational diabetes
EP2902783B1 (de) * 2012-09-28 2017-08-30 Sekisui Medical Co., Ltd. Additiv zur messung einer verdünnten probe in einem reagens einer immunchromatografischen methode ohne verdünnung
AR094118A1 (es) * 2012-12-20 2015-07-08 Novartis Ag Lesion renal aguda
CN103105489B (zh) * 2013-01-23 2014-12-24 深圳市亚辉龙生物科技有限公司 检测自身免疫性疾病抗体的免疫印迹试剂盒及其制备方法
CN104764882A (zh) * 2014-08-20 2015-07-08 苏州和锐医药科技有限公司 一种抗bpi-anca抗体检测试纸条的制备方法及应用
WO2017064555A1 (en) * 2015-10-05 2017-04-20 Seinda Biomedical Corporation Methods and devices for diagnosing ocular surface inflammation anddry eye disease
CN107389925B (zh) * 2017-07-28 2019-03-29 上海交通大学医学院附属上海儿童医学中心 用于脓毒症快速诊断的il-6和il-10二联胶体金免疫层析试剂盒
GB202004972D0 (en) * 2020-04-03 2020-05-20 Neutrocheck Ltd Blood analysis method
CN112946259A (zh) * 2021-02-02 2021-06-11 瑞莱生物科技江苏有限公司 降钙素原、白介素6和肝素结合蛋白联合检测试剂盒
CN116068207A (zh) * 2023-03-24 2023-05-05 山东康华生物医疗科技股份有限公司 一种用于检测nk细胞活性的试剂盒

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4663277A (en) * 1983-05-20 1987-05-05 Profile Diagnostic Sciences Inc. Virus detection method and materials
ATE161963T1 (de) * 1989-06-06 1998-01-15 Ampcor Inc Reagenziensatz für immunoassay
DE69230000T2 (de) * 1991-07-19 2000-05-11 Cytimmune Sciences Inc Verfahren und testsatz zur messung von endogenen zytokinen
US5369036A (en) * 1992-07-02 1994-11-29 Becton, Dickinson And Company Enhancement of signal in immunoassays using microparticles which contain different detectable substances
US5643875A (en) * 1994-01-24 1997-07-01 Friedmann; Nadav Human therapeutic uses of bactericidal/permeability increasing (BPI) protein products
US6414218B1 (en) * 2000-01-18 2002-07-02 The General Hospital Corporation Mouse model for rheumatoid arthritis
WO2001060320A2 (en) * 2000-02-18 2001-08-23 Vanderbilt University TREATMENT OF INFLAMMATION WITH p20
EP1340086B1 (de) * 2000-10-17 2008-07-30 Besst-Test Aps Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe

Also Published As

Publication number Publication date
JP2004511802A (ja) 2004-04-15
AU2001295442A1 (en) 2002-04-29
US20040048274A1 (en) 2004-03-11
ES2257446T3 (es) 2006-08-01
EP1340077A1 (de) 2003-09-03
EP1340077B1 (de) 2006-01-25
WO2002033408A1 (en) 2002-04-25
DE60116889D1 (de) 2006-04-13
DE60116889T2 (de) 2006-09-14

Similar Documents

Publication Publication Date Title
ATE316653T1 (de) Test zum direkten nachweis eines inflammatorischen anzeiger in einer körperflüssigkeitsprobe
ATE489633T1 (de) Verfahren zum frühzeitigen nachweis herzerkrankungen
ATE256869T1 (de) Probendetektion zum initiieren der zeitmessung eines elektrochemischen tests
CA2465800A1 (en) Instrument
ATE510208T1 (de) Probenanalyseverfahren und probenanalyseeinrichtung
DE602004030586D1 (de) Verfahren zur verwendung von cytokintests zur diagnose, behandlung und beurteilung von ankyloider spondylitis
BG104275A (en) Method and device for express analysis of tested parameters in biological samples
CA2459007A1 (en) Sucker rod dimension measurement and flaw detection system
ATE403153T1 (de) Test zum direkten nachweisen einer rs virus bezogenen biologischen zelle in einer körperflüssigkeitsprobe
EP1519190A3 (de) Flüssigkeitssensoreinrichtung zur dynamischen Prüfung von Flüssigkeiten
WO2003011108A3 (en) Access pressure ratio device and testing method
WO2000074553A3 (en) Gas analyzer calibration checking device
BR9915637A (pt) Dispositivo de medição de múltiplos produtos quìmicos e tiras de teste
CY1106932T1 (el) Ενας δοκιμαστικος μοχλος
WO2005031005A3 (en) Compositions, methods and kits for determining the presence of trichomonas vaginalis in a test sample
ATE541048T1 (de) Verfahren und vorrichtung zum nachweisen und/oder bestimmen der in einer probe enthaltenen bakterien
ATE528102T1 (de) Verfahren zum prüfen einer rotationsachse mit einer selbstzentrierenden messvorrichtung
ATE302947T1 (de) Verfahren zum nachweis eines lipoprotein- akutphaseprotein-komplexes
DE60041456D1 (de) Verfahren und vorrichtung zum nachweis einer gasblase in einer flüssigkeit
FI20030992A (fi) Menetelmä hydrometeoreja havaitsevan mittalaitteen yhteydessä sekä tähän liittyvä laitteisto
DE602004021673D1 (de) Verfahren und vorrichtungen zur gewichtsmessung
AR005521A1 (es) Metodo para vigilar un proceso microbiologico en una fuente de fluidos que tiene poblacion microbiologica.
WO2009053870A3 (en) Device and method for the monitoring of the movement of cells
Rinn Principles and challenges of static load tests (‘pull-testing’) for estimating uprooting safety
JP2006038597A (ja) 埋設管の検査方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties